PROPOFOL
ANTHEA PHARMA · PROPOFOL
Open FDA's page for this record- Application number
- ANDA220857
- Sponsor name
- ANTHEA PHARMA
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20260714
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Products
- Product number
- 001
- Reference drug
- No
- Brand name
- PROPOFOL
- Reference standard
- No
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- PROPOFOL
- Strength
- 10MG/ML
- Harmonized identifiers (openFDA)
- Application number
- ANDA220857
- Brand name
- PROPOFOL
- Generic name
- PROPOFOL
- Manufacturer name
- Anthea Pharma Private Limited
- Product NDC
- 83854-018
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAVENOUS
- Substance name
- PROPOFOL
- RxCUI
- 1808224
- SPL ID
- 5c98e309-8b86-4513-e063-6294a90aa881
- SPL set ID
- f23fe3c5-aa37-4ecc-ad76-f13c1a1dabe2
- Package NDC
- 83854-018-01, 83854-018-10, 83854-018-16, 83854-018-14, 83854-018-15
- Nui
- N0000175975, N0000175681
- Pharm class pe
- General Anesthesia [PE]
- Pharm class epc
- General Anesthetic [EPC]
- UNII
- YI7VU623SF
